IP Verse

Treatment Of Coccidiosis With Intramuscular Triazine Compositions - EP3566695

The patent EP3566695 was granted to Ceva Sant Animale on Aug 5, 2020. The application was originally filed on Dec 6, 2013 under application number EP19180399A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3566695

CEVA SANT ANIMALE
Application Number
EP19180399A
Filing Date
Dec 6, 2013
Status
Granted And Under Opposition
Jul 3, 2020
Grant Date
Aug 5, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELANCOMay 5, 2021POTTER CLARKSONWITHDRAWN
BAYER ANIMAL HEALTHAug 5, 2020VON RENESSEWITHDRAWN

Patent Citations (33) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONDE19603984
DESCRIPTIONDE19824483
DESCRIPTIONEP0116175
DESCRIPTIONEP0201030
DESCRIPTIONEP0879057
DESCRIPTIONEP2164196
DESCRIPTIONEP2164496
DESCRIPTIONUS2010179151
DESCRIPTIONUS4219552
DESCRIPTIONUS5219853
DESCRIPTIONUS6465460
DESCRIPTIONWO0126660
DESCRIPTIONWO2006058426
DESCRIPTIONWO2007140610
DESCRIPTIONWO2009111794
OPPOSITIONCA2688613
OPPOSITIONCN101947201
OPPOSITIONCN102512366
OPPOSITIONCN102743334
OPPOSITIONDE102007025908
OPPOSITIONDE102009038949
OPPOSITIONEP2276347
OPPOSITIONEP3566695
OPPOSITIONUS2010179151
OPPOSITIONUS3536696
OPPOSITIONUS7915257
OPPOSITIONWO0019964
OPPOSITIONWO2014086959
OPPOSITIONWO2019233870
SEARCHDE102007025908
SEARCHDE102009038949
SEARCHUS6465460
SEARCHWO0214288

Non-Patent Literature (NPL) Citations (38) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "22.6 - Kokzidiose", HEINRITZI ET AL., SCHWEINEKRANKHEITEN, Stuttgart, (20060000), pages 165 - 166, XP055679151-
OPPOSITION- 5m Editor, "Coccidiosis in Piglets", The Pig Site, (20090302), pages 1 - 9, XP055954923-
OPPOSITION- A HARPER, "Injection Use and Quality Assured Pork", Virginia Cooperative Extension, (20000500), pages 1 - 3, XP055954768-
OPPOSITION- Anonymous, "Stop Coccidiosis in Piglets!", Baycox 5% Toltrazuril coccidiocide for piglets, (20030000), pages 1 - 17, XP055954932-
OPPOSITION- "Baycox 5%® ad us. vet., orale Suspension", (200809), URL: https://www.vetpharm.uzh.ch/tak/05000000/00056127.01, (20200422), XP055706737-
OPPOSITION- "Baycox® 5% - Toltrazuril - Coccidiocide for piglets", Technical Information, (20030100), pages 1 - 31, XP055453605-
OPPOSITION- ECKERT et al., LEHRBUCH DER PARASITOLOGIE FUR DIE TIERMEDIZIN, Stuttgart, (20080000), page 611, XP055706770-
OPPOSITION- ECKERT et al., LEHRBUCH DER PARASITOLOGIE FÜR DIE TIERMEDIZIN, Stuttgart, (20080000), pages 82 - 83, XP055679156-
OPPOSITION- EMA, "CVMP assessment report for Forceris (EMEA/V/C/004329/0000) International non-proprietary name: toltrazuril/ iron (iii) ion", (20190421), XP055605322-
OPPOSITION- "Gleptosil 200mg/ml solution for injection", Summary of Products Characteristics, (201506), XP055825097-
OPPOSITION- GRIESSLER et al., SCHWEINEKRANKHEITEN - ERKENNEN UND ERFOLGREICH BEHANDELN, (20080000), pages 92 - 93, XP055825082-
OPPOSITION- HABERKORN A. et al., "Studies on the Activity Spectrum of Toltrazuril*, a New Anti-Coccidial Agent", Veterinary Medical Review, (19870000), vol. 1, no. 87, pages 22 - 32, XP055825026-
OPPOSITION- H.-C. MUNDT, "Baycox 5%: An anticoccidial for the treatment of isospora suis coccidiosis in piglets", 16th Congress of the International Pig Veterinary Society, (20000900), XP055453518-
OPPOSITION- HEINRITZI et al., "Eisenmangelanämie", Schweinekrankheiten, Stuttgart, (20060000), pages 52 - 54, XP055702028-
OPPOSITION- HEINRITZI et al., SCHWEINEKRANKHEITEN, Stuttgart, (20060000), pages 44 - 46, XP055825076-
OPPOSITION- "How to administer iron for piglets", URL: http://www.uniferon.com/learning-center/how-to-administer-iron-for-piglets.aspx-
OPPOSITION- "Iron Dextran", Registry, CAS, Database accession no. 9004-66-4-
OPPOSITION- JORDAN et al., POULTRY DISEASES, 4th ed., (19960000), pages 261 - 267, XP055706783-
OPPOSITION- J STERLE, "Off to the Right Start - baby pig basics", Texas Agricultural Extension Service, (20000800), pages 1 - 3, XP055954763-
OPPOSITION- LONG, THE BIOLOGY OF THE COCCIDIA, (19820000), page 15, 28, XP055706878-
OPPOSITION- "Modern pig farming - pig farming front line - what kind of diseases occur in pigs between summer and autumn", Animal Husbandry in the North, (20080915), XP055825064-
OPPOSITION- MO, "Which kind of disease occurs in pigs between summer and autumn", Animal Husbandry in the North, (20080000), pages 1 - 2, XP055825064-
OPPOSITION- MUNDT et al., "Efficacy of a Bycox® plus iron suspension formulation for the control of neonatal porcine coccidiosis", Proceedings of the 22nd International Pig Veterinary Society Congress (IPVS 2012 Korea), (20120000), page 552, XP055679160-
OPPOSITION- Mundt H C; Joachim A, "Efficacy of a Bycox® plus iron suspension formulation for the control of neonatal porcine coccidiosis", 22nd International Pig Veterinary Society Congress (IPVS 2012 Korea), (20120610), page 552, XP055679160-
OPPOSITION- Naciri, "Coccidiosis in chicken", INRA Handbook, (2000), XP055706872-
OPPOSITION- SALLE E. et al., "Comparative Study of the Efficacy of Gleptoferron and Iron Dextran in Anaemia Prevention in Piglets", 19th IPVS Congress, Copenhagen, Denmark, (20060000), page 567, XP055825110-
OPPOSITION- Salsbury Manual of Poultry Diseases, 7th ed., (19820000), pages 13 - 15, XP055706779-
OPPOSITION- Taylor D J, "PIG DISEASES Sixth edition", PIG DISEASES Sixth edition, ST Edmundsbury Press, (19950000), pages 274 - 277, XP055954627-
OPPOSITION- Taylor D. J., "Piglet Enteritis from 10 Days to Weaning", The Pig Journal, (19960000), pages 158 - 174, XP055825043-
OPPOSITION- TAYLOR, "Piglet enteritis from 10 days to weaning", The Pig Journal, (19960000), vol. 36, pages 158 - 174, XP055825043-
OPPOSITION- "URSOFERRAN® 150 mg/ml per os", Fachinformation, (20050819), XP055702024-
OPPOSITION- WALDMANN et al., "Chapters 4, 9 and 13", Lehrbuch der Schweinekrankheiten, (20010000), pages 49-54, 188-192 - 369-370, XP055954836-
OPPOSITION- WALDMANN et al., LEHRBUCH DER SCHWEINEKRANKHEITEN, Berlin, (20010000), pages 49-54, 188 - 192, 369-371, XP055825053-
OPPOSITION- Zuidema J., Pieters F.A.J.M., Duchateau G.S.M.J.E., "Release and absorption rate aspects of intramuscularly injected pharmaceuticals", International Journal of Pharmaceutics, (19880000), vol. 47, no. 1-3, pages 1 - 12, XP025554495
OPPOSITION- HABERKORN et al., "Animal Models of Coccidia Infection", Handbook of Animal Models of Infection, (19990000), doi:10.1016/B978-012775390-4/50238-4, pages 821 - 838, XP055706790
OPPOSITION- Meeus Joke, Scurr David J., Appeltans Bernard, Amssoms Katie, Annaert Pieter, Davies Martyn C., Roberts Clive J., Van Den Mooter Guy, "Influence of formulation composition and process on the characteristics and in vitro release from PLGA-based sustained release injectables", European Journal of Pharmaceutics and Biopharmaceutics, (20150000), vol. 90, pages 22 - 29, XP029203761
SEARCH- -, "Baycox (R) 5% Toltrazuril - Coccidiocide for Piglets - Technical Information", BAYER, (200301), pages 1 - 31, XP055453605 [Y] 1-13 * page 19 * * page 21 *-
SEARCH- PAN B L ET AL, "Effect of subcutaneously administered diclazuril on the output of Eimeria species oocysts by experimentally infected rabbits", VETERINARY RECORD, BRITISH VETERINARY ASSOCIATION, LONDON, GB, (20080202), vol. 162, no. 5, doi:10.1136/VR.162.5.153, ISSN 0042-4900, pages 153 - 155, XP009166529 [Y] 1-13 * page 153, column r, paragraph l *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents